Transactions

Our broad-based transaction experience extends across a range of situations, industries and enterprise values

Type

Industry

Republic of Ecuador

Announced: January 27, 2026
Value: $4.0 billion
Status: Closed

Exclusive financial advisor to the Republic of Ecuador on its Eurobond issuance

SEEQC, Inc.

Announced: January 16, 2026
Value: $1 billion
Status: Pending

Financial advisor to SEEQC on its agreement to combine with Allegro Merger Corp, supported by a $65 million PIPE financing

Equity Residential

Announced: May 21, 2026
Value: $69bn
Status: Pending

Centerview served as lead financial advisor to Equity Residential in their merger with AvalonBay Communities

Emalex Biosciences

Announced: April 29, 2026
Value: Up to $900mm
Status: Pending

Financial Advisor on its sale to Teva

KalVista Pharmaceuticals Inc.

Announced: April 29, 2026
Value: $1.9bn
Status: Pending

Financial Advisor to KalVista on its sale to Chiesi

Neurona

Announced: April 17, 2026
Value: Up to $1.15bn
Status: Pending

Centerview as exclusive financial advisor to Neurona on its sale to UCB

Gilead

Announced: April 7, 2026
Value: Up to $5.0bn
Status: Pending

Financial advisor to Gilead on its acquisition of Tubulis

Soleno

Announced: April 6, 2026
Value: $2.9bn
Status: Pending

Lead financial advisor to Soleno on its sale to Neurocrine

TMRW Life Sciences

Announced: April 2, 2026
Status: Pending

Centerview as sole financial advisor to TMRW on their merger and Series E

Versigent

Announced: April 1, 2026
Status: Pending

Centerview as financial advisor to Aptiv in its separation of Versigent

Showing 1 to 10 of 10
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please let us know if you would like to learn more about a career at Centerview.
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers. Learn more about who we are.
New York

Centerview Partners LLC


31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP


1 Sherwood Street

6th Floor

London W1F 7BL

02074099700 | Tel
02074099704 | Fax
Paris

Centerview Partners France SCS


51 Avenue Hoche


Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC


1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC


555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax





Copyright © 2008 - 2026 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC